• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eton Pharmaceutcials Inc (NQ: ETON )

8.350 -0.270 (-3.13%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eton Pharmaceutcials Inc

< Previous 1 2 3 4 5 6 Next >
Critical Insights From Eton Pharmaceuticals Analyst Ratings: What You Need To Know
October 28, 2024
Via Benzinga
SWK Holdings Provides Portfolio Update
October 17, 2024
Via ACCESSWIRE
3 Stocks Insiders Are Buying Heavily In October 2024, And Why
October 09, 2024
Should investors add these stocks on their watchlist? Insider buys suggest so. 
Via Talk Markets
Domino's Pizza To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Friday
October 04, 2024
Via Benzinga
Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen
October 03, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
Recap: Eton Pharmaceuticals Q4 Earnings
March 14, 2024
Via Benzinga
Eton Pharmaceuticals Earnings Preview
March 13, 2024
Via Benzinga
Is NASDAQ:ETON suited for growth investing?
March 06, 2024
ETON PHARMACEUTICALS INC (NASDAQ:ETON) may be suited for growth investing, we'll explore why in this article. 
Via Chartmill
Why the growth investor may take a look at NASDAQ:ETON.
February 14, 2024
Exploring ETON PHARMACEUTICALS INC (NASDAQ:ETON)'s growth characteristics. 
Via Chartmill
Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
August 22, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024
August 08, 2024
ETON stock results show that Eton Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results
August 08, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
July 30, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
Evaluating NASDAQ:ETON for Growth Investment Opportunities.
January 22, 2024
Exploring ETON PHARMACEUTICALS INC (NASDAQ:ETON)'s growth characteristics. 
Via Chartmill
Eton Pharmaceuticals: Q3 Earnings Insights
November 09, 2023
Via Benzinga
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
July 17, 2024
Via ACCESSWIRE
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
July 15, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
ETON Stock Earnings: Eton Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
May 09, 2024
ETON stock results show that Eton Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
May 09, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference
May 01, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
April 30, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
April 29, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 22, 2024
Via Benzinga
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
March 22, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023
March 14, 2024
ETON stock results show that Eton Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
March 14, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024
February 29, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
Earnings Scheduled For March 14, 2024
March 14, 2024
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter. 
Via Benzinga
Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation
February 21, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules
February 02, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap